Skip to content

Effect of Music Therapy on Infants With Neonatal Abstinence Syndrome

The Effect of Music Therapy on Neonates Diagnosed With Neonatal Abstinence Syndrome: A Pilot Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03533985
Enrollment
200
Registered
2018-05-23
Start date
2017-11-01
Completion date
2026-12-31
Last updated
2026-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

NAS

Keywords

Neonatal Abstinence Syndrome, Music therapy, Attachment, Music medicine, Multi-modal stimulation

Brief summary

This study examines the effects of 6 different music therapy interventions on outcomes for neonates diagnosed with Neonatal Abstinence Syndrome.

Detailed description

The purpose of this exploratory pilot study is to learn what, if any, effects live music therapy interventions have on the pacification, stabilization, and development of infants diagnosed with Neonatal Abstinence Syndrome (NAS). Neonatal Abstinence Syndrome is a group of problems that occur in a newborn who has been exposed to illegal or prescription opiates while in the mother's womb. Participants will receive 6 music therapy sessions over a 14-day period based on a randomized treatment schedule of 6 different interventions.

Interventions

BEHAVIORALSong of Kin

Music therapists will assess meaningful song/theme (of choice/culture) and provide musical elements in a way that nurtures parents. They will then develop a simplified part of the theme into a soothing lullaby for their infants to be utilized directly by the parent/s and/or the music therapist to comfort, engage or sedate.

OTHERGato box

Depending on the time of intervention and need of the infant the music therapist will provide rhythmic entrainment that follows the heart rate or suck patterns of the infant

OTHEROcean disc

Depending on the time of intervention and needs of the infant the music therapist will provide a whoosh sound using the Remo Ocean disc. It will be entrained to the infant's respiratory rate.

OTHERContingent singing

Depending on the state of the infant, the music therapist will provide short segments of conversant prosody, to enhance quiet-alert, or stimulate relaxation/sleep

OTHERTonal Vocal holding

Music therapist will provide a vowel, long held tone, sung without vibrato

OTHERMuted shaker

If infant is awake, the muted shaker will be used to entrain to the infant's vital signs-to comfort, soothe or sedate

Sponsors

Icahn School of Medicine at Mount Sinai
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Parents of infants will be unaware of the interventions' effects. Outcomes Assessor will be unfamiliar with desired outcomes.

Intervention model description

Counterbalancing will be achieved by assigning a different order of presentation of conditions for each group. Participants will remain in the study for two weeks, but continue to receive music therapy for the duration of their stay in the NICU.

Eligibility

Sex/Gender
ALL
Age
28 Weeks to No maximum
Healthy volunteers
No

Inclusion criteria

Infants who meet the following inclusion criteria will be eligible to participate in the study irrespective of race, religion, ethnicity, or gender: * Admitted to the NICU immediately postpartum * Gestational age 28 weeks or older * No identified hearing disorder * Do not have a diagnosed developmental disability (i.e. Down Syndrome) * Do not have Fetal Alcohol Syndrome * Medically cleared to participate in the study by nurse or neonatologist * Parent or legal guardian able/willing to give consent \& complete the PBQ (Postpartum Bonding Questionnaire)

Exclusion criteria

* Admitted to the NICU at any time other than immediately postpartum * Gestational age \<28 weeks old * Has an identified hearing disorder * Has diagnosed developmental disability (i.e. Down syndrome) * Has Fetal Alcohol Syndrome * Is not medically cleared to participate in the study by the nurse or neonatologist * Parent or legal guardian unable/unwilling to give consent

Design outcomes

Primary

MeasureTime frameDescription
Heart Rateup to 2 weeks
Respiratory Rateup to 2 weeks
O2 satsup to 2 weeksOxygen saturation levels (O2 sats)
Activity levelup to 2 weeksThe neonatologist or nurse will assess and mark as active/alert, active to stimulation, flaccid, hypertonic, hypotonic, irritable, jittery, lethargic, paralyzed\&medicated, quiet, sedated, or tremors
Sleep categoryup to 2 weeksThe neonatologist or nurse will assess and mark as quiet sleep, active sleep, drowsy state, alert inactivity, fussing or crying.
Feeding (sucking and absorption) categoryup to 2 weeksThe neonatologist or nurse will rate feeding (sucking/absorption) from 1 (active/perpetual) to 12 (none/gavage)
Neonatal Abstinence Scoring (NAS)up to 2 weeksThe NAS score lists 21 symptoms that are most frequently observed in opiate-exposed infants. Each symptom and its associated degree of severity are assigned a score and the total abstinence score is determined by totalling the score assigned to each symptom over the scoring period. Please provide the full scale info (example 0 (no symptoms) to 10 (severe symptoms)

Secondary

MeasureTime frameDescription
Postpartum Bonding Questionnaire (PBQ )BaselineQuestionnaire to assess capacity for attachment in both mothers and fathers. 25 item scale with each item rated from always to never. Scoring is based on four categories: impaired bonding scores 0-60, rejection and pathological anger scores 0-35, infant-focused anxiety scores 0-20, and incipient abuse scores 0-10. Total range from 0 (good bonding) to 125 (poor bonding).

Countries

United States

Contacts

CONTACTJoanne Loewy, DA, LCAT, MT-BC
joanne.loewy@mountsinai.org212-420-3484
CONTACTElizabeth Barone, MA, MT-BC, CCLS
Elizabeth.Barone@mountsinai.org
PRINCIPAL_INVESTIGATORJoanne Loewy, PhD

Icahn School of Medicine at Mount Sinai

PRINCIPAL_INVESTIGATORKathy Murphy, PhD

Loyola University

STUDY_DIRECTORAimee Telsey, MD

Icahn School of Medicine at Mount Sinai

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 23, 2026